JP1674775S - - Google Patents

Info

Publication number
JP1674775S
JP1674775S JPD2020-7214F JP2020007214F JP1674775S JP 1674775 S JP1674775 S JP 1674775S JP 2020007214 F JP2020007214 F JP 2020007214F JP 1674775 S JP1674775 S JP 1674775S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-7214F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-7214F priority Critical patent/JP1674775S/ja
Priority to US29/753,311 priority patent/USD978699S1/en
Application granted granted Critical
Publication of JP1674775S publication Critical patent/JP1674775S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-7214F 2020-04-06 2020-04-06 Active JP1674775S (Direct)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-7214F JP1674775S (Direct) 2020-04-06 2020-04-06
US29/753,311 USD978699S1 (en) 2020-04-06 2020-09-30 Operating panel for elevator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-7214F JP1674775S (Direct) 2020-04-06 2020-04-06

Publications (1)

Publication Number Publication Date
JP1674775S true JP1674775S (Direct) 2020-12-14

Family

ID=73741322

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-7214F Active JP1674775S (Direct) 2020-04-06 2020-04-06

Country Status (2)

Country Link
US (1) USD978699S1 (Direct)
JP (1) JP1674775S (Direct)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1060095S1 (en) 2021-04-02 2025-02-04 Otis Elevator Company Operation panel for the disabled

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD401268S (en) * 1997-01-03 1998-11-17 C. van Ijsselmuide Electronic Business Gifts B.V. Calculator
USD418820S (en) * 1998-08-14 2000-01-11 Sony Corporation Remote controller
USD438237S1 (en) * 2000-07-10 2001-02-27 Limax Electronics Co., Ltd. Calculator
USD483796S1 (en) * 2002-01-14 2003-12-16 Hua Wen Hsu Calculator with frames
USD596977S1 (en) * 2007-12-05 2009-07-28 Mitsubishi Electric Corporation Control panel for elevator
USD678795S1 (en) * 2011-04-13 2013-03-26 Mitsubishi Electric Corporation Control panel for elevator
USD679210S1 (en) * 2011-04-13 2013-04-02 Mitsubishi Electric Corporation Control panel for elevator
USD681493S1 (en) * 2011-04-13 2013-05-07 Mitsubishi Electric Corporation Control panel for elevator
USD696601S1 (en) * 2011-04-13 2013-12-31 Mitsubishi Electric Corporation Control panel for elevator
USD674352S1 (en) * 2011-04-21 2013-01-15 Mitsubishi Electric Corporation Operating panel for elevator
USD803815S1 (en) * 2015-05-06 2017-11-28 Fm Marketing Gmbh Wireless remote control
USD844613S1 (en) * 2017-12-15 2019-04-02 SimpliSafe, Inc. Keypad

Also Published As

Publication number Publication date
USD978699S1 (en) 2023-02-21

Similar Documents

Publication Publication Date Title
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134206A1 (es) Degradantes y usos de los mismos
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos